Trial Profile
A phase I trial of TL 000139 [milataxel] in patients with advanced malignant solid tumors
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 19 Jan 2006
Price :
$35
*
At a glance
- Drugs Milataxel (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 19 Jan 2006 New trial record.